We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$9.27B
AUM Growth
+$916M
Cap. Flow
-$3.89M
Cap. Flow %
-0.04%
Top 10 Hldgs %
35.73%
Holding
278
New
28
Increased
73
Reduced
150
Closed
24

Top Buys

Rank Stock Value
1
GAP
The Gap Inc
GAP
+$73.5M
2
ROKU icon
Roku
ROKU
+$44.7M
3
AFRM icon
Affirm
AFRM
+$40.4M
4
OSCR icon
Oscar Health
OSCR
+$34.6M
5
GKOS icon
Glaukos
GKOS
+$23M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Consumer Discretionary 21.49%
3 Communication Services 15.02%
4 Healthcare 14.51%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EME icon
176
Emcor
EME
$33.1B
$2.62M 0.03%
5,763
-190
-3% -$89.9K
PODD icon
177
Insulet
PODD
$9.52B
$2.6M 0.03%
9,955
-127
-1% -$32K
BURL icon
178
Burlington
BURL
$14.6B
$2.54M 0.03%
8,911
-328
-4% -$88.6K
FIP icon
179
FTAI Infrastructure
FIP
$343M
$2.52M 0.03%
346,428
-12,240
-3% -$105K
TGTX icon
180
TG Therapeutics
TGTX
$8.25B
$2.45M 0.03%
81,292
+16,394
+25% +$470K
PRIM icon
181
Primoris Services
PRIM
$4.06B
$2.42M 0.03%
+31,691
New +$2.32M
ARGX icon
182
argenx
ARGX
$61.8B
$2.4M 0.03%
3,895
-14
-0.4% -$8.2K
AXON
183
Axon Enterprise
AXON
$37.1B
$2.36M 0.03%
+3,970
New +$2.16M
NKE icon
184
Nike
NKE
$54.2B
$2.31M 0.02%
30,488
-36,040
-54% -$2.83M
APP icon
185
Applovin
APP
$111B
$2.08M 0.02%
6,422
-179
-3% -$45.3K
BRK.B icon
186
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.01M 0.02%
4,425
WSO icon
187
Watsco Inc
WSO
$12.7B
$1.95M 0.02%
4,106
-135
-3% -$68.4K
EWCZ
188
DELISTED
European Wax Center
EWCZ
$1.89M 0.02%
283,351
+12,034
+4% +$79.2K
DESP
189
DELISTED
Despegar.com
DESP
$1.8M 0.02%
93,473
+1,010
+1% +$15.9K
APA icon
190
APA Corp
APA
$16.2B
$1.79M 0.02%
77,325
-9,407
-11% -$220K
RCUS icon
191
Arcus Biosciences
RCUS
$3.03B
$1.77M 0.02%
119,050
-7,336
-6% -$120K
ANF icon
192
Abercrombie & Fitch
ANF
$5.97B
$1.73M 0.02%
11,569
-3,155
-21% -$461K
CCO icon
193
Clear Channel Outdoor Holdings
CCO
$1.22B
$1.65M 0.02%
1,206,396
-229,644
-16% -$351K
RDDT icon
194
Reddit
RDDT
$31.1B
$1.63M 0.02%
+10,002
New +$1.23M
MRVL icon
195
Marvell Technology
MRVL
$200B
$1.63M 0.02%
+14,738
New +$1.37M
SARO
196
StandardAero Inc
SARO
$7.73B
$1.46M 0.02%
+58,840
New +$1.7M
PCVX icon
197
Vaxcyte
PCVX
$8.81B
$1.35M 0.01%
16,550
+42
+0.3% +$4.17K
BBIO icon
198
BridgeBio Pharma
BBIO
$14B
$1.35M 0.01%
49,230
-182
-0.4% -$4.7K
CRNX
199
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.28M 0.01%
25,044
+12,429
+99% +$695K
KRUS icon
200
Kura Sushi USA
KRUS
$488M
$1.27M 0.01%
14,038
+6,973
+99% +$652K

Similar funds

Gilder Gagnon Howe & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Gilder Gagnon Howe & Co held 278 positions worth $9.27B, up 11% from $8.36B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2024 filing shows 28 new, 73 increased, 150 reduced and 24 closed positions. Its largest new stake was Roivant Sciences: 1,162,986 shares worth $13.8M. The largest sale was Lantheus, an estimated $36.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Gilder Gagnon Howe & Co's largest Q4 2024 buy was Roivant Sciences: 1,162,986 shares worth $13.8M.
  • Gilder Gagnon Howe & Co added most to The Gap Inc in Q4 2024, an estimated $73.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2024 reduction was Lantheus, cutting an estimated $36.8M.
  • Gilder Gagnon Howe & Co fully exited Newmont in Q4 2024, selling an estimated $21.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $9.27B portfolio in Q4 2024.
  • Gilder Gagnon Howe & Co opened 28 new positions and closed 24 in Q4 2024.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $9.27B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2024, filed 14 Feb 2025.